Enzyme Replacement Therapy During Pregnancy in Fabry Patients: Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating Pregnancy

Fabry disease (FD) is an X-linked, lysosomal storage disease. Mutations in the gene coding for alpha-galactosidase A lead to globotriaosylceramide (Gb-3) accumulation in lysosomes and in placenta and umbilical cord. Impact of FD and treatment with enzyme replacement (ERT) on foetal development is un...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JIMD Rep
Autors principals: Madsen, Christoffer V., Christensen, Erik Ilsø, Nielsen, Rikke, Mogensen, Helle, Rasmussen, Åse K., Feldt-Rasmussen, Ulla
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323029/
https://ncbi.nlm.nih.gov/pubmed/30117110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2018_129
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars